Economic and social burden of drug intoxications in Morocco: prognostic analysis of 1,787 cases and development of a medico-economic model

Authors

  • Aida Soulaymani Instituts Supérieurs des professions Infirmières et Techniques de Santé - ISPITS -Rabatt
  • Hanane Chaoui Poison Control and Pharmacovigilance Center of Morocco (CAPM), Rabat, Morocco
  • Houda Sefiani Poison Control and Pharmacovigilance Center of Morocco (CAPM), Rabat, Morocco

DOI:

https://doi.org/10.63883/ijsrisjournal.v3i6.830

Keywords:

drug intoxication, economic burden, cost of illness, societal costs, toxicovigilance, logistic regression, Morocco, PubMed

Abstract

Introduction: Drug intoxications lead to healthcare utilization and economic consequences that extend beyond hospital expenditure alone. In Morocco, national toxicovigilance data make it possible to identify profiles associated with prognosis and resource mobilization, but their economic burden remains poorly documented.

Objective: To identify the determinants of vital prognosis and length of hospital stay, then to develop a parameterized Moroccan model of the economic and social burden integrating direct costs, productivity losses, premature mortality, justice/social services, and quality of life.

Methods: Retrospective analytical study of 1,787 cases reported to the Poison Control and Pharmacovigilance Center of Morocco (CAPM) between 1980 and 2008. The epidemiological analysis focused on logistic regression of death, description of time to hospital discharge using Kaplan-Meier analysis, and the ROC curve of the prognostic model. A targeted literature synthesis, limited to PubMed and to publications from 2017–2024, searched for parameters on direct costs, resource utilization, productivity, premature mortality, justice/social services, and quality of life/QALY. The economic model follows a bottom-up approach based on the principle of quantity × Moroccan unit cost. It aims at a contemporary and parameterizable valuation, not a reconstruction of historical expenditures from 1980–2008.

Results: Sixteen deaths were observed (case fatality rate 0.90%). In the multivariable analysis on complete cases (n=1,493; 14 deaths), cannabis-based products were associated with lower odds of death than other substances (aOR=0.16; 95%CI 0.04–0.61; p=0.007). The apparent discrimination of the model was moderate (AUC=0.724; 95%CI bootstrap 0.595–0.841). Among the 51 cases with recorded length of hospital stay, the median was 2 days and the mean was 13.8 days, reflecting a strongly skewed distribution of resource consumption. The PubMed synthesis made it possible to structure a societal cost model distinguishing care, non-medical costs, productivity, premature mortality, justice/social services, and quality of life. As an illustration, applying a published Moroccan direct cost of 157 USD per episode corresponds to 280,559 USD for 1,787 episodes; this amount does not constitute a measure of expenditures actually incurred by the historical cohort.

Conclusion: Toxicovigilance data make it possible to identify clinical markers useful for resource stratification and for building a medico-economic model. The proposed framework is transparent and updatable, but a complete national estimate will require prospective data on unit costs, professional activity, household expenditure, judicial events, and quality of life.

Keywords: drug intoxication; economic burden; cost of illness; societal costs; toxicovigilance; logistic regression; Morocco; PubMed.

 

 

Received Date: November 05, 2024

Accepted Date: November 26, 2024

Published Date: December 01, 2024

Available Online at: https://www.ijsrisjournal.com/index.php/ojsfiles/article/view/830

Downloads

Download data is not yet available.

Author Biographies

Hanane Chaoui, Poison Control and Pharmacovigilance Center of Morocco (CAPM), Rabat, Morocco

Hanane Chaoui, MD, PhD, is a physician specializing in sports medicine and holds a PhD in epidemiology. She joined the Moroccan Poison Control and Pharmacovigilance Centre (CAPM) in 2009, where she works in toxicological information and serves as Head of the Toxicovigilance Department. Her activities focus on the analysis of poisoning cases, toxicovigilance signal detection, and the management of databases related to psychoactive substances and heavy metals. She also contributes to national projects on chemical risks and health vigilance, training in pharmacovigilance and toxicovigilance, and the supervision of academic research. She is also Vice-President of the Moroccan Society of Clinical and Analytical Toxicology and Secretary-General of the Moroccan Association for Health, Environment and Toxicovigilance (AMSETOX).

Houda Sefiani, Poison Control and Pharmacovigilance Center of Morocco (CAPM), Rabat, Morocco

Houda Sefiani, PhD, is a specialist in pharmaco-toxicology with a doctoral degree in health vigilance. She has been working at the Moroccan Poison Control and Pharmacovigilance Centre (CAPM) since 2007, where her activities have focused on case assessment, causality analysis, signal detection, risk minimization, and the development of pharmacovigilance and toxicovigilance systems. She served as Head of the National Pharmacovigilance Centre from 2021 to 2022 before being appointed Director of the Moroccan Poison Control and Pharmacovigilance Centre.

Dr. Sefiani has participated in numerous training and capacity-building initiatives in collaboration with the World Health Organization (WHO), the Uppsala Monitoring Centre (UMC), and other international pharmacovigilance programs, with particular emphasis on strengthening pharmacovigilance systems in Africa and the MENA region. Since 2017, she has also contributed to francophone training programs in pharmacovigilance and to the evaluation and improvement of national vigilance systems.

Downloads

Published

2024-12-01

How to Cite

Soulaymani, A., Chaoui, H. ., & Sefiani, H. (2024). Economic and social burden of drug intoxications in Morocco: prognostic analysis of 1,787 cases and development of a medico-economic model. International Journal of Scientific Research and Innovative Studies, 3(6), 202–209. https://doi.org/10.63883/ijsrisjournal.v3i6.830